{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"NovoCure Limited"},"Symbol":{"label":"Symbol","value":"NVCR"},"Address":{"label":"Address","value":"GRENVILLE STREET,NO. 4 THE FORUM, SECOND FLOOR, ST. HELIER, JE2 4UF, Jersey"},"Phone":{"label":"Phone","value":"+44 1534756700"},"Industry":{"label":"Industry","value":"Medical/Dental Instruments"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"Europe"},"CompanyDescription":{"label":"Company Description","value":"NovoCure Ltd serves in the healthcare sector of the United States. Its business involves commercial-stage oncology operations involving therapies to cure critical tumors. Its pipeline consists of Ovarian Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer, and Brain Metastasis. NovoCure derives its major revenues in the United States."},"CompanyUrl":{"label":"Company Url","value":"https://www.novocure.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Asaf Danziger","title":"Chief Executive Officer & Director"},{"name":"Moshe Giladi","title":"Chief Science Officer"},{"name":"Nicolas Leupin","title":"Chief Medical Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}